By www.reliablemarketsize.com
Global Polycythemia Vera Treatment Market Research Report 2024 Story
116
$ 2900
Polycythemia Vera Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
ANP Technologies, INC. Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd. Galena Biopharma, Inc. Gilead Sciences, Inc Italfarmaco S.P.A. Karus Therapeutics Limited Miragen Therapeutics, Inc Zydus Cadila Incyte Corp. Otsuka America Pharmaceutical, Inc. Pharmaclon Teva Pharmaceuticals Inc. Schering-Plough GNC Vector Alfarm Merk and Co. Inc. Pfizer. Novartis AG Bayer AG Mylan N.V GlaxosmithKline plc